Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis

Objectives. To systematically collate, appraise, and synthesize the current evidence on the Xuebijing injection (XBJI) for sepsis. Methods. Eight databases were searched for systematic reviews (SRs) or meta-analyses (MAs) on XBJI for sepsis. Assessing the Methodological Quality of Systematic Reviews...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sa Tian, Defang Qin, Yixuan Ye, Huawei Yang, Shuguang Chen, Tao Liu, Luming Hu, Huiming Li, Qian Niu, Xingzhan Zhang
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/76667ccadb9f4eafbab92b5ec7cbbc66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:76667ccadb9f4eafbab92b5ec7cbbc66
record_format dspace
spelling oai:doaj.org-article:76667ccadb9f4eafbab92b5ec7cbbc662021-11-08T02:36:01ZScientific Evidence of Xuebijing Injection in the Treatment of Sepsis1741-428810.1155/2021/6879278https://doaj.org/article/76667ccadb9f4eafbab92b5ec7cbbc662021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/6879278https://doaj.org/toc/1741-4288Objectives. To systematically collate, appraise, and synthesize the current evidence on the Xuebijing injection (XBJI) for sepsis. Methods. Eight databases were searched for systematic reviews (SRs) or meta-analyses (MAs) on XBJI for sepsis. Assessing the Methodological Quality of Systematic Reviews-2 (AMSTAR-2), Preferred Reporting Item for Systematic Reviews and Meta-Analyses (PRISMA), and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methods were used to assess the methodological quality, reporting quality, and evidence quality of the enrolled studies, respectively. Results. Out of the 13 studies that were included, all studies were rated critically low quality based on AMSTAR-2 results. Based on the results obtained from PRISMA, all studies were reported to be over 80%, while the GRADE system yielded three outcome measures rated high-quality, 16 were of moderate quality, and the rest were of low or critically low quality. Conclusions. The combination of XBJI and Western medicine (WM) showed significant synergy for the treatment of sepsis compared to WM alone. However, this conclusion should be treated with caution since the quality of the SRs/MAs providing the evidence was relatively low.Sa TianDefang QinYixuan YeHuawei YangShuguang ChenTao LiuLuming HuHuiming LiQian NiuXingzhan ZhangHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Other systems of medicine
RZ201-999
spellingShingle Other systems of medicine
RZ201-999
Sa Tian
Defang Qin
Yixuan Ye
Huawei Yang
Shuguang Chen
Tao Liu
Luming Hu
Huiming Li
Qian Niu
Xingzhan Zhang
Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
description Objectives. To systematically collate, appraise, and synthesize the current evidence on the Xuebijing injection (XBJI) for sepsis. Methods. Eight databases were searched for systematic reviews (SRs) or meta-analyses (MAs) on XBJI for sepsis. Assessing the Methodological Quality of Systematic Reviews-2 (AMSTAR-2), Preferred Reporting Item for Systematic Reviews and Meta-Analyses (PRISMA), and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methods were used to assess the methodological quality, reporting quality, and evidence quality of the enrolled studies, respectively. Results. Out of the 13 studies that were included, all studies were rated critically low quality based on AMSTAR-2 results. Based on the results obtained from PRISMA, all studies were reported to be over 80%, while the GRADE system yielded three outcome measures rated high-quality, 16 were of moderate quality, and the rest were of low or critically low quality. Conclusions. The combination of XBJI and Western medicine (WM) showed significant synergy for the treatment of sepsis compared to WM alone. However, this conclusion should be treated with caution since the quality of the SRs/MAs providing the evidence was relatively low.
format article
author Sa Tian
Defang Qin
Yixuan Ye
Huawei Yang
Shuguang Chen
Tao Liu
Luming Hu
Huiming Li
Qian Niu
Xingzhan Zhang
author_facet Sa Tian
Defang Qin
Yixuan Ye
Huawei Yang
Shuguang Chen
Tao Liu
Luming Hu
Huiming Li
Qian Niu
Xingzhan Zhang
author_sort Sa Tian
title Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
title_short Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
title_full Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
title_fullStr Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
title_full_unstemmed Scientific Evidence of Xuebijing Injection in the Treatment of Sepsis
title_sort scientific evidence of xuebijing injection in the treatment of sepsis
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/76667ccadb9f4eafbab92b5ec7cbbc66
work_keys_str_mv AT satian scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT defangqin scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT yixuanye scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT huaweiyang scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT shuguangchen scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT taoliu scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT luminghu scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT huimingli scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT qianniu scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
AT xingzhanzhang scientificevidenceofxuebijinginjectioninthetreatmentofsepsis
_version_ 1718443197001105408